Results 171 to 180 of about 5,887,855 (243)
Restoring the Airway Barrier: How Targeting Eosinophilic Inflammation Shapes Epithelial Health and Clinical Remission in Asthma. [PDF]
Gasperovic S +2 more
europepmc +1 more source
Cardiovascular Outcomes With Dupilumab Versus Omalizumab in Severe Asthma
Clinical &Experimental Allergy, EarlyView.
Po‐Cheng Shih +2 more
wiley +1 more source
Patients with severe ICI‐induced liver injury are commonly treated with corticosteroids, but the optimal tapering strategy remains uncertain. In this study, a gradual corticosteroid tapering strategy based partly on Japanese clinical practice for autoimmune hepatitis was associated with a low rate of relapse and enabled many patients to safely resume ...
Naoto Soma +7 more
wiley +1 more source
Setting National Allergy Priorities for Research in Australia: A Priority Setting Consumer Survey
Clinical &Experimental Allergy, EarlyView.
Rachel L. Peters +10 more
wiley +1 more source
Novel and emerging skin carcinomas and adnexal tumours
The present review aims to provide an overview of the main emerging skin epithelial tumours, with particular emphasis on salivary gland analogue sweat gland tumours and poorly differentiated carcinomas. Epidermal and adnexal tumours of the skin constitute a complex and heterogeneous group of neoplasms, with distinct morphology and behaviour.
Thibault Kervarrec +2 more
wiley +1 more source
Benralizumab in Severe Eosinophilic Asthma: Toward Disease Control and Evolving Treatment Paradigms. [PDF]
Maglio A +8 more
europepmc +1 more source
Eosinophilic Lung Disease: Accompanied with 12 Cases. [PDF]
Sevim T +5 more
europepmc +1 more source
Eczema and Lung Function Across the Life Course: A Systematic Review
Clinical &Experimental Allergy, EarlyView.
Mohammed K. Alghasham +8 more
wiley +1 more source
Poorly differentiated lung adenocarcinomas with concurrent anaplastic lymphoma kinase (ALK) and CD30 expression closely mimic ALK‐positive anaplastic large‐cell lymphoma, creating a significant diagnostic pitfall. Accurate classification requires comprehensive integration of clinical, radiologic, morphologic, immunophenotypic and molecular findings ...
Jietian Jin +6 more
wiley +1 more source
This study supports the need for ancillary testing to diagnose ESC‐RCC versus TFEB‐amplified RCC, as neither morphology nor immunohistochemistry is sufficiently specific to distinguish these entities. The underlying molecular drivers in each tumour are pathogenic TSC1 or TSC2 gene variants in ESC‐RCC and TFEB gene amplification in TFEB‐amplified RCC ...
Hayley Zullow +3 more
wiley +1 more source

